Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
- DOI
- 10.1186/s13058-015-0524-0
- Published
- 2015-02-11
- Container
- Breast Cancer Res
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13058-015-0524-0,
title = {Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.},
author = {Kren BT and Unger GM and Abedin MJ and Vogel RI and Henzler CM and Ahmed K and Trembley JH.},
year = {2015},
journal = {Breast Cancer Res},
doi = {10.1186/s13058-015-0524-0},
url = {https://doi.org/10.1186/s13058-015-0524-0}
}RIS
TY - JOUR TI - Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. AU - Kren BT AU - Unger GM AU - Abedin MJ AU - Vogel RI AU - Henzler CM AU - Ahmed K AU - Trembley JH. PY - 2015 JO - Breast Cancer Res DO - 10.1186/s13058-015-0524-0 UR - https://doi.org/10.1186/s13058-015-0524-0 ER -
APA
BT, K., GM, U., MJ, A., RI, V., CM, H., K, A., & JH., T. (2015). Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.. Breast Cancer Res. https://doi.org/10.1186/s13058-015-0524-0
Source records
- europe-pmc · retrieved 2026-09-26T20:22:29.037Z